A detailed history of Edgestream Partners, L.P. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Edgestream Partners, L.P. holds 19,306 shares of MEDP stock, worth $6 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
19,306
Previous 13,071 47.7%
Holding current value
$6 Million
Previous $5.38 Million 19.6%
% of portfolio
0.29%
Previous 0.26%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$320.58 - $457.29 $2 Million - $2.85 Million
6,235 Added 47.7%
19,306 $6.44 Million
Q2 2024

Aug 09, 2024

BUY
$372.0 - $424.34 $4.86 Million - $5.55 Million
13,071 New
13,071 $5.38 Million
Q4 2023

Feb 14, 2024

SELL
$227.52 - $312.68 $829,765 - $1.14 Million
-3,647 Reduced 67.57%
1,750 $536,000
Q3 2023

Nov 14, 2023

BUY
$233.98 - $281.67 $1.26 Million - $1.52 Million
5,397 New
5,397 $1.31 Million
Q1 2023

May 15, 2023

BUY
$174.31 - $239.52 $1.73 Million - $2.38 Million
9,937 New
9,937 $1.87 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.66B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Edgestream Partners, L.P. Portfolio

Follow Edgestream Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.